NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported fourth-quarter net income of $214 million.
The New York-based company said it had net income of 38 cents per share. Earnings, adjusted for non-recurring costs, came to $1.46 per share.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.33 per share.
The company posted revenue of $622 million in the period. Its adjusted revenue was $874 million.
For the year, the company reported profit of $771 million, or $1.37 per share. Revenue was reported as $3.25 billion.
Royalty Pharma expects full-year revenue in the range of $3.28 billion to $3.43 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX
